Lisa Sideris: The Power of Plasma Donation in Alpha 1 Care
Lisa Sideris, Alpha-1 Patient Advocate and Rare Disease Speaker at Alpha-1 Foundation, shared a post on LinkedIn:
“900.
That’s the exact number of plasma donations it takes each year to provide the therapy needed to keep just one Alpha 1 patient alive and breathing.
I shared that statistic on Capitol Hill this week with the Congressional Plasma Caucus, alongside the Plasma Protein Therapeutics Association (PPTA) .
The room went silent.
Before I was diagnosed with Alpha 1 Antitrypsin Deficiency, a rare genetic disease that affects the lungs and liver, my reality looked like this:
- 3 years searching for answers
- 7 to 10 different specialists
- A portion of my left lung removed completely unnecessarily
Today, plasma derived therapies remain essential and while we work toward new treatments, we must make sure patients who rely on plasma today continue to have access to the therapies they need.
No donors mean no treatment. Its really that simple.
To everyone who has ever sat in a chair to donate plasma: thank you.
You aren’t just a donor.
You’re someone’s 900.”
David McIntosh, Founder and Chair of United Plasma Action, shared Lisa Sideris’s post on LinkedIn:
“This post is a striking reminder of how important Alpha 1 Antitripsin is for the patients who need it.
Made from precious human plasma donations, Alpha 1 has no effective alternatives or substitutes and yet is NOT always given the policy priority that it deserves.
Attention please, all Health Authorities and Regulators.”

Stay updated with Hemostasis Today.
-
Oct 4, 2026, 15:06Vasiliki Gkalea: Journal of Clinical Medicine Launches Special Issue on Hematologic Thrombosis and Bleeding
-
Oct 4, 2026, 14:55Quentin Brebant: What Defines a High-Quality Red Blood Cell Concentrate?
-
Oct 4, 2026, 14:47Rana Al-Hrout: Recognizing Non-Anemic Iron Deficiency – Why Iron Matters Beyond Hemoglobin
-
Oct 4, 2026, 14:41David McIntosh: International Plasma Awareness Week 2026 – Closing the Global Plasma Gap
-
Oct 4, 2026, 14:33Pete Stibbs: CleanerVac Real-World Study Presented at VIVA and The VEINS 2026
-
Oct 4, 2026, 13:56Maria Elisa Mancuso: EHC 2026 Highlights the Unmet Needs of Women with Bleeding Disorders
-
Oct 4, 2026, 13:53Nirmal Shaji George: Individualizing Anticoagulation in Complex APS and Thrombocytopenia
-
Oct 4, 2026, 13:5210 Posts Not to Miss This Week
-
Oct 4, 2026, 13:45Suswapna Singh Rawat: The Clinical Significance of Coronary Plaque Stability